BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Policy

  Elite Pharmaceuticals and SunGen Pharma File ANDA

  Under the terms of the Agreement, the product will be owned jointly by Elite and SunGen.

  February 8, 2018

   · 

  4 min read
• Drug Development

  Vifor Pharma Ferroportin Inhibitor Enters Phase-I Clinical Trial

  VIT-2763 is an orally administered small molecule developed by Vifor Pharma. I

  February 8, 2018

   · 

  3 min read
• Business

  Vectura Group plc Notice of Preliminary Results

  Vectura Group plans to announce its Preliminary Results for the 12 months ended 31 December 2017 on Wednesday 21 March 2018.

  February 8, 2018

   · 

  1 min read
• Business

  Intercept to Report 2017 Full Year Financial Results on February 14 and Present at Upcoming Conferences

  Management will conduct a conference call and audio webcast on Wednesday, February 14, 2018 at 8:30 a.m. Eastern Time to discuss these results.

  February 8, 2018

   · 

  1 min read
• Drug Development

  CILcare’s Age-Related Hearing Loss Model Enriched With NAC as Positive Control

  The antioxidant, NAC, delays the senescence process by slowing the age-related hearing loss and protecting cochlear hair cells of SAMP8 mice.

  February 8, 2018

   · 

  3 min read
• joimax Continues Strong Growth Trend in 2017 with Launch of Its MultiZYTE Facet and SI Joint Treatment Set in the U.S.

  The joimax announces very strong sales figures for 2017.

  February 8, 2018

   · 

  3 min read